Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats

British Journal of Anaesthesia

Volumn 110, Issue SUPPL.1, 2013, Pages

  Brucken A ^a   Cizen, A ^a   Fera, C ^a   Meinhardt, A ^a   Weis, J ^a   Nolte, K ^a   Rossaint, R ^a   Pufe, T ^a   Marx, G ^a   Fries, M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

argon; cardiopulmonary resuscitation; hypoxia ischaemia, brain

Indexed keywords

ARGON; NITROGEN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HEART ARREST; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; MALE; NEOCORTEX; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SCORING SYSTEM; SPRAGUE DAWLEY RAT;

EID: 84878604737     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes509     Document Type: Article

References (44)

1. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, et al. Out of hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 15: 1500-5
2. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-63
3. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 2008; 359: 21-30
4. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA,Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. J Am Med Assoc 2009; 302: 2222-9
5. Neumar RW, Nolan JP, Adrie C, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452-83
6. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004; 30: 2126-8
7. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346: 557-63
8. HaCAS Group. Mild therapeutic hypothermia to improve the neurological outcome after cardiac arrest. N Engl J Med 2002; 346: 549-56
9. Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M. Xenon: recent developments and future perspectives. Minerva Anestesiol 2009; 75: 37-45
10. Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008; 36: 588-95
11. Dingley J, Tooley J, Porter H, Thoresen M. Xenon provides shortterm neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006; 37: 501-6
12. Luo Y, Ma D, Ieong E, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008; 109: 782-9
13. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002; 89: 739-46
14. Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005; 102: 929-36
15. Fries M, Nolte KW, Coburn M, et al. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 2008; 36: 2420-6
16. Fries M, Brucken A, Cizen A, et al. Combining xenon and mild therapeutic hypothermia preserves neurologicalal function after prolonged cardiac arrest in pigs. Crit Care Med 2012; 40: 1297-303
17. Yarin YM, Amarjargal N, Fuchs J, et al. Argon protects hypoxia-, cisplatin-and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Heart Res 2005; 201: 1-9
18. Loetscher PD, Rossaint J, Rossaint R, et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009; 13: R206
19. Jawad N, Rizvi M, Gu J, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460: 232-6
20. Ryang YM, Fahlenkamp AV, Rossaint R, et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2011; 39: 1448-53
21. Zhuang L, Yang T, Zhao H, et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012; 40: 1724-30
22. Stark RA, Nahrwold ML, Cohen PJ. Blind oral tracheal intubation of rats. J Appl Physiol 1981; 51: 1355-6
23. Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005; 66: 175-91
24. Neumar RW, Bircher NG, Sim KM, et al. Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation 1995; 29: 249-63
25. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003; 463: 3-33
26. Behnke AR. Respiratory resistance, oil-water solubility, and mental effects of argon, compared with helium and nitrogen. Am J Physiol 1939; 126: 409-15
27. Soldatov PE, D'Iachenko AI, Pavlov BN, Fedotov AP, Chuguev AP. Survival of laboratory animals in argon-containing hypoxic gaseous environments. Aviakosm Ekolog Med 1998; 32: 33-7
28. Antonov AA, Ershova TA. Retention of the skill to perform adaptive bio-control of bioelectrical activity synchronization in the human brain cortex in an argon-nitrogen-oxygen atmosphere with various oxygen content. AviakosmEkologMed 2009; 43: 27-31
29. Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, Ma D. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood) 2010; 235: 886-91
30. David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One 2012; 7: e30934
31. Ryang YM, Fahlenkamp AV, Rossaint R, et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2011; 39: 1448-53
32. Neigh GN, Glasper ER, Bilbo SD, Traystman RJ, Courtney DeVries A. Cardiac arrest/cardiopulmonary resuscitation augments cell-mediated immune function and transiently suppresses humoral immune function. J Cereb Blood Flow Metab 2005; 25: 1424-32
33. Mulley GP, Wilcox RG, Harrison MJ. Plasma cortisol as a measure of stress response in acute stroke. Stroke 1989; 20: 1593
34. Woolf PD, Cox C, Kelly M, Nichols D, McDonald JV, Hamill RW. The adrenocortical response to brain injury: correlation with the severity of neurological dysfunction, effects of intoxication, and patient outcome. Alcohol Clin Exp Res 1990; 14: 917-21
35. Olsson T, Asplund K, Hagg E. Pituitary-thyroid axis, prolactin and growth hormone in patients with acute stroke. J Intern Med 1990; 228: 287-90
36. Kiprianova I, Freiman TM, Desiderato S, et al. Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat. J Neurosci Res 1999; 56: 21-7
37. Schabitz WR, Berger C, Kollmar R, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 2004; 35: 992-7
38. Ferrer I, Ballabriga J, Marti E, Perez E, Alberch J, Arenas E. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol 1998; 8: 253-61
39. Callaway CW, Ramos R, Logue ES, Betz AE, Wheeler M, Repine MJ. Brain-derived neurotrophic factor does not improve recovery after cardiac arrest in rats. Neurosci Lett 2008; 445: 103-7
40. D'Cruz BJ, Fertig KC, Filiano AJ, Hicks SD, DeFranco DB, Callaway CW. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab 2002; 22: 843-51.
41. Ma D, Hossain M, Pettet GK, et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006; 26: 199-208
42. Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ. Gammaaminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 2003; 96: 746-9, table of contents
43. Randall RD, Thayer SA. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci 1992; 12: 1882-95
44. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-6